1-Methyltryptamine is primarily explored for its psychoactive properties, often studied in the context of neuroscience and pharmacology. It acts as a serotonin receptor agonist, making it a subject of interest for research into mood regulation, perception, and consciousness. Its structural similarity to serotonin allows it to mimic its effects, which is useful in studying the serotonin system's role in mental health disorders like depression and anxiety. Additionally, it has been investigated for its potential use in psychotherapy, particularly in altering states of consciousness to facilitate therapeutic breakthroughs. However, its application remains largely experimental and is not widely adopted in clinical practice due to limited research and regulatory constraints.